SBI Securities’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
6CM
KGAMU
WPM
RC
QOP
SBI Securities's CDLX Position: Q2 2026 in Review
SBI Securities reduced its Cardlytics (CDLX) stake by 50% in Q2 2026, selling an estimated $7 and leaving 1 share worth $4. The position accounts for ﹤0.01% of the portfolio, ranked #4001.
SBI Securities first reported a position in CDLX in Q4 2024 and has held it in 7 quarters since. The position peaked at $271 in Q1 2025. 42 funds tracked by Wall St. Rank hold CDLX as of Q2 2026.
- SBI Securities held 1 share of Cardlytics worth $4 as of Q2 2026.
- SBI Securities sold 1 Cardlytics share in Q2 2026, an estimated $7.
- Cardlytics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #4001 holding.
- SBI Securities first reported a position in Cardlytics in Q4 2024 and has held it in 7 quarters since.
- SBI Securities's Cardlytics position peaked at $271 in Q1 2025.
- 42 funds tracked by Wall St. Rank held Cardlytics as of Q2 2026.
Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.